Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
YSOTOPE THERANOSTICS logo — Targeted radiopharmaceuticals for precision oncology

YSOTOPE THERANOSTICS

Targeted radiopharmaceuticals for precision oncology

Founded 2022 Spain Spain 2 employees Seed Health Care, Pharmaceutical

General Information

Company Name YSOTOPE THERANOSTICS
Founded Year 2022
Location Spain Spain
Employees 2
Industries Health Care, Pharmaceutical
Funding Stage Seed
Business Model B2B
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with YSOTOPE THERANOSTICS. To contact YSOTOPE THERANOSTICS, visit ysotope.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does YSOTOPE THERANOSTICS compare?

A PDF of YSOTOPE THERANOSTICS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting YSOTOPE THERANOSTICS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About YSOTOPE THERANOSTICS

YSOTOPE THERANOSTICS is a pioneering startup founded in 2022, specializing in the development of targeted radiopharmaceuticals for precision oncology. Headquartered in Spain, the company is strategically positioned within the Health Care and Pharmaceutical industries, sectors known for their growth potential and high investor interest.

Driven by its core mission to design, validate, and monetize its innovative solutions, Ysotope is committed to advancing precision medicine in oncology through its cutting-edge technologies. The recent Seed Round investment on 29 March 2023, with funding from Lanzadera Accelerator, Spanish Angels Capital, Biozell Ventures, and EDEM Business School, underlines strong confidence from notable investors. This funding will likely accelerate Ysotope's R&D efforts and enhance its market positioning.

With its promising technology and strategic investor backing, Ysotope Theranostics stands out as a significant player poised to disrupt the precision oncology landscape.

Business keywords: Targeted Radiopharmaceuticals, Precision Oncology, Radiotracers, Co-diagnostic Solutions, Molecular Imaging, CAR-T Cell Monitoring, Deeptech Entrepreneurship, Radiochemistry, Non-invasive Diagnostics, Oncology Innovation, Biotechnology Startups, Healthcare Solutions, Patient-specific Therapies, Medical Imaging, Biopharmaceutical Development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 4
Lanzadera Accelerator Spanish Angels Capital
Lanzadera Accelerator, Spanish Angels Capital +2
29 Mar 2023

YSOTOPE THERANOSTICS Alternatives & Competitors

View All Alternatives
YSOTOPE THERANOSTICS vs
Clarity Pharmaceuticals
Clarity Pharmaceuticals Australia

Clarity is developing next-generation products to address the growing need for radiopharmaceuticals...

Venture round
61 employees
Biotechnology, Health Care
YSOTOPE THERANOSTICS vs
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. United States

Targeted α-Particle Radiotherapy for Cancer

Grant
10 employees
Biotechnology, Health Care
YSOTOPE THERANOSTICS vs
Abion Inc.
Abion Inc. Korea South

ABION, pioneering precision oncology in lung cancer and infectious disease solutions

Venture round
23 employees
Health Care, Pharmaceutical
View all alternatives

FAQ About YSOTOPE THERANOSTICS

Targeted radiopharmaceuticals for precision oncology
YSOTOPE THERANOSTICS was founded in 2022.
YSOTOPE THERANOSTICS is headquartered in Spain.
YSOTOPE THERANOSTICS operates in Health Care and Pharmaceutical. Its work centres on Targeted Radiopharmaceuticals, Precision Oncology, Radiotracers and Co-diagnostic Solutions.
YSOTOPE THERANOSTICS has a B2B business model. Its revenue comes from Product Sales and Licensing.
YSOTOPE THERANOSTICS has approximately 2 employees.
YSOTOPE THERANOSTICS has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to YSOTOPE THERANOSTICS include Clarity Pharmaceuticals, Viewpoint Molecular Targeting, Inc., Abion Inc., MultiplexDX International, RayzeBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
YSOTOPE THERANOSTICS and Clarity Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for YSOTOPE THERANOSTICS, https://bouncewatch.com/company/ysotope-theranostics, updated 26 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes